Home / 2022

Eli Lilly‘s Mounjaro (tirzepatide): clinical study and its potential as a weight loss medicine

It would be very interesting to see whether Lilly’s share price will rise along with the marketing of Mounjaro. After all, the clinical research of this drug cost USD2.8 billion. article from Cartkoo.com/weight-loss-updates Recently, The New England Journal of Medicine published the result of the “SURMOUNT-1” study on the efficacy and safety of GLP-1/GIP dual-channel […]

Can I take Acarbose for weight loss?

Firstly, Acarbose is a hypoglycemic drug, not a weight loss drug, so doctors wll not recommend people to take acarbose tablets to lose weight. If you are not a diabetic, taking this drug may cause hypoglycemia, along with possible gastrointestinal reaction. Acarbose is an α-glucosidase inhibitor, which inhibits α-glucosidase in the gastrointestinal tract, reducing carbohydrate […]